EUCTR2016-003329-40-FR招募中1 期
eovascular glaucoma prevention by intravitreal injections of anti-VEGF in patients treated by protontherapy in case of large choroid melanoma
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- CHU de Nice
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •- Age = 18 years
- •- Choroid melanoma more than 7 mm thick and / or over basal diameter of 15mm treated by proton therapy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 56
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Iris melanoma
- •- Melanoma immediately metastatic
- •- Pregnant or breastfeeding women
- •- Known hypersensitivity to aflibercept (anti-VEGF selected)
研究者
相似试验
已完成
不适用
Intravitreal injection of anti vascular endothelial growth factor agent, Lucentis (ranibizumab), for the treatment of retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000013975agoya University hospital ophtalmoligy30
已完成
不适用
Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract SurgeryPharmacological ActionNCT05428683Emad Abdel Aal Saliem84
尚未招募
不适用
Intravitreal aflibercept injection for exudative age-related macular degeneratioAge-Related Macular DegenerationJPRN-UMIN000010997Department of Ophthalmology, Fukushima Medical University School of Medicine50
已完成
不适用
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20
进行中（未招募）
1 期
Panitumumab to prevent the progression of eyeball elongation in adults with nearsightedness and macular degeneratioAdult highly myopic patients with myopic macular degenerationEye DiseasesISRCTN96896687fa Eye Research Institute20